>>Oh, welcome back to theCube coverage of AWS re:Invent Executive Summit presented by Accenture. I'm John,  your host of theCube. We're joined by two great guests, Leo Barella, Chief Technology Officer of Takeda and Don Heiliger Managing Director at Accenture. Gentlemen, welcome to theCube. >> Thank you. Great to be here.  >>Last year, Karl Hick joined us to discuss Takeda's cloud journey. I know a lot's gone by the pandemic. Didn't go away as fast as we hoped, but we're starting to see visibility of the future with cloud at narrow and seeing cloud scale. Um, it's refactoring of business models, new opportunities. How's it gone? >>Well, I think it's a, it's going wonderful, as planned actually.  I can, I can share with you that there are definitely some lessons learned, uh, what the plan was quite structured. We definitely discovered that  maybe we should have actually had about 50% of our time, uh, in the planning for organizational change management and communication. And because we definitely, uh, want to, uh, be able to kind of explain why, uh, moving to cloud is actually important to, to our business. Uh, and so, so if you were to actually do it again, uh, I think we would have probably put a lot more time in communicating the value of the program and wild visibly. Now, uh, we're going to be able to move a lot faster than a, than a year ago. Uh, seeing that the community of the Qaeda is, uh, is already, you know, kind of come around, uh, to, to truly understand the value of, uh, of, uh, moving to cloud >>No last year, any Jessie gave up on stage the keys to success for the cloud journey, you guys were in the middle of it. Um, what was the big takeaway, um, on the, on, on your, your journey, because a lot of people are having real situational awareness and doubling down on successes, identifying what's not working and being real agile. This has been the big aha. What's the big aha moments you had, uh, this year? >>Well, I can tell you that. I say from the, the migration of our applications to cloud, which, which is basically table stakes for elimination of our data centers. So at the end of the program, we're likely gonna retain only few application in our data centers, but move more than 80% of our application workloads to cloud. What actually most excited about is, uh, is really our new strategy around data as a digital platform enabler. Uh, so from now on we're, we're really going to be focusing on the value stream of the Qaeda at the understanding of, of digital platforms that we actually want to able to, to, to further consolidate, um, and, um, uh, you know, and globally expand, uh, the, the, the technologies that we have, but old built on a data foundation, uh, that, that is actually governed across the community of the Qaeda. So data actually becomes the center of our strategy. Uh, and then digital is basically just a way for us to actually interact with data, uh, which includes applications, such as machine learning and AI, which we were heavily investing in. And, uh, and we definitely plan on now leveraging more and more. >>And just to real quick, before we go to a central for a second, I want you to double down on that journey dynamics because we're seeing and maybe reporting, and the theme here this year at reinvent is multiple workloads in the cloud changing workloads. You have evolution of workloads, data as the center of it. And then this cultural shifts where you got the, you know, these modern applications at the top of the stack. So you were AIS contributing. So you've got three major innovation theaters kind of exploding. I mean, this is pretty, I mean, one of those is, is mindblowing. Nevermind, all three. >>Yeah. And I can tell you that, uh, you know, um, I'd like to achieve further expand the circle, uh, beyond the Qaeda. We don't necessarily believe that the digital transformation is just about, I don't want enterprise. That is definitely a fundamental, uh, but the digital transformation is truly about, um, connecting the Qaeda as a digital, uh, pharmaceutical company to the overall healthcare ecosystem and be able to basically transact with our partners, uh, in real time, which is the reason why we actually put data at the center because at the end of the day, uh, when other partners wants to interact with our data, the should in real time be able to transact as if they were transacting on their own systems with our own data, especially DCPS and patients, >>Don your, your reaction, because a lot of learnings, new opportunities, you're at the center of essentially doing a lot of great work. We've been documented a lot of it as well. What's your reaction? >>I mean, I just to amplify a lot of Leo's comments already, I think if I, if I think back and on this journey with, with the Qaeda and AWS and Accenture as the power of three, I think, you know, leaning in to that has been a recipe for success. So as Leo said, we've definitely had some lessons learned, but you know, being there with this power of three, I think has been, uh, enabling us to, uh, attack those challenges that have, uh, that have come up and, and really gotten ahead of those. I think the other thing you talked about is this, um, you know, all these different things coming together, you know, before the pandemic, we had, uh, done done some research at Accenture that kind of had two groups of companies with the leader leaders and the laggards. And, uh, it showed, know the difference in revenue growth of the leaders that adopt technology and those that are falling behind and really, um, that gap has widened, but there's a new entrance of companies that have emerged, which is the, leapfroggers the ones that take advantage of all of the things that like AWS has to offer in terms of the AI capabilities, the data capabilities, the foundational elements that are enabling them to really do this compressed transformation journey in a much shorter timeline. >>I think that's been the element that, uh, you know, I think we know you and I have firsthand together with our AWS colleagues of us being able to really do this on a pace that I think has just been on, on the unseen or unmatched in the past. >>Well, we get to the innovation pilots you guys are doing. I want to just jump on that topic for a quick second time. If you don't mind, that's a really important point. I think the people who shifted to the cloud and replatformed, and then learned all the goodness and then refactored their businesses have done great. This notion of leapfrog is people who move and say, Hey, I don't need, I'm going to replatform and refactor at the same time, get the learnings from others. Okay. They get the best practice is so what's the scar tissue from all the pioneers who have been playing in the cloud, who got the benefits are also paving the path for others. This is actually a motivating, cultural and personal kind of impact motivation. People are happier. What's your guys' reaction to this culture of the cloud, this cloud reef, leapfrogging and refactoring. >>Yeah. I mean, uh, w what I'm saying, uh, and, and lovely, or your perspective on this too, but frankly, you know, I think, uh, you know, with, with the, uh, the war on talent right now, that's out there. I think, you know, companies are investing, whether they're leaders, whether they're leapfroggers in this digital, uh, you know, platform I think are attracting the best talent and actually making it a place where people can innovate. And I know we're going to talk about some of the innovations here in a second, but I think that is, um, you know, some, a way to differentiate, uh, right now in the marketplace, given everything that we're seeing around, uh, retention and attraction of talent. I mean, being able to be on the front edge of this is quite critical in any company's view, but, you know, especially when you're trying to attract the best talent in, in, uh, developing, uh, medicines that actually say lots, >>Leo jumping on this wave and moving leapfrogging, what's your perspective on this? >>Yeah. You know, I, I agree to, uh, you know, talent is that talent is key. Uh, and quite frankly, uh, you know, Takeda, we've been at, you know, pharmaceutical company for the past 240 years. Uh, and now what should you really, uh, you know, starting to become a digital, um, pharmaceutical, uh, power. Uh, and, and so, uh, part of the attractiveness of, uh, of joining Takeda for instance, is the fact that, uh, not only you actually get to, uh, you know, uh, be with a company that is investing heavily, uh, in, in, in digital re-skilling and actually training of people, but also you're connecting to the mission of, uh, of literally saving saving lives, right? So basically, uh, the, the, the connection of really this transformation to become a digital superpower, uh, and also, uh, the, the mission of, uh, of really finding new medicines were, uh, for people that actually experienced, you know, for instance, you know, order of disease, uh, it's quite exciting because it's, uh, it's the application of artificial intelligence machine learning, uh, where now you're actually really trying to find someone that is, that is struggling. Uh, and we're now actually connecting them to a cure that, that is drastically changing their lifestyle. >>It's interesting, the agile agility and the speed of innovation really kind of puts away the old analysis of like, what's the payback. I mean, if you, if you can't see the value right away, then you, then you don't know what you're doing. Basically people in the cloud that say I can contribute and leapfrog and get that value. This has been a big part of the business model. And one of the ways people are doing it is just getting involved, starting pilots, doing the projects. Um, so I'd like to have you guys share the project that you guys have got going on with nurse line. Can you share what you're trying to achieve and how has the cloud enabled you to, to innovate, but also capture the value and can, and can you see it, is there, is there a big analysis there's like a big payback it's like you're buying this 20 year project, or how do you guys look at this? >>I mean, the nimbleness of, uh, of cloud, uh, in our ability to come in and fail fast is what's extremely attractive to, uh, to, to the business, right? Because now all of a sudden we can quickly spin up a prototype. We can quickly actually put it out as a product and actually see how effective it is compared to traditional processes. Uh, so for instance, nurse line is actually what we, uh, it's one of the many, uh, innovation initiatives that we actually have going on, but specifically addressing, uh, one of our, um, uh, therapy areas, which is, uh, our plasma derived therapies, uh, plasma and other therapies is actually, uh, the supply chain actually really starts with, uh, the good wheel of a innovative individual like yourself, um, deciding to actually not donate plasma that eventually is being processed and fractionated to deliver medicines that are life savings in most cases is actually the, the literally life savings. >>Um, and, uh, so what we're trying to do is actually really make that experience as flawless as, uh, in, as seamless as possible. Uh, if you, if you, if you have ever experienced, you know, going into Amazon go, uh, where you kind of, you know, walk in, you get some groceries and walk out and don't pass through a register. And, uh, it's the same type of experience that we actually want to provide where, uh, in the past, um, when you're actually donating plasma, obviously it's a, it's a fairly invasive procedure because obviously you need to actually be in a, being a bad and your, your plasma is getting distracted, but there's a lot of paperwork that you need to actually fill in. And, uh, and what we actually did, uh, is now actually enabled that through a digital experience where a donor, uh, they do a short approaching the center can now actually initiate a chat with, uh, with Amazon connect the ILX. >>Uh, and then, uh, depending on the priority, uh, the donor is going to assign to a nurse that can actually be anywhere in the country. Uh, in all of a sudden the nurse can actually initiate, uh, through, through Amazon connect, um, a dialogue with the, you know, with, with the donor, uh, answering some of the questions in the, you know, in the regular questionnaire. So, so now all of a sudden the nurse is actually feeding up the people work for you. Uh, and, uh, and that is actually done through the initiation of a video call. Uh, and we're actually using chime, which is, again, a part of like, you know, the, the, you know, the, the Amazon AWS services. And then basically upon the, the completion of a, of the questionnaire that is action, analytic, Tronic signature, that has been applied to, um, you know, to the form. >>Uh, and so did, this is actually all happening while basically the person is actually walking through the center or walking into the center. Uh, and now all of a sudden, the only thing that they need to do is actually having a signed bat and, uh, and actually initiate the process of, uh, of plasma donation. So all of this is actually done through microservices. Uh, now everything that we do now is actually API enabled and, you know, obviously like many other companies right now, what I should really think about microservices and the usability of, of technology and, and reusable components. So we're extremely excited about the fact that now, uh, that experience can actually be carried on, uh, to, to other parts of the business and that, that, that can actually leverage these technologies. >>That's a great example of refactoring. What's next for you guys, a division Accenture, what's the plans? >>Well, again, uh, the Google got done. >>Well, I was going to say, I mean, I think, you know, we, we started touching on it, uh, experience, right. And, uh, how do we embed more technology experiences that we're all used to? I mean, you know, to get into some of the return to office, the easiest way for me to do some of the COVID testing has been using my, uh, my trusty iPhone. Right. And so, as, as Liam talked about that experience, uh, part of this beyond just the therapies and, and attracting donors is really key for any business to succeed and thrive. Um, yeah, I think it, you know, if you think about, um, you've got the natives that are really more technology-based, you've got the, the Peloton of the world that obviously have, you know, a platform, but also a product you're going to see product and specifically life sciences companies get more into platform enabled, uh, services that they can provide outside, uh, as a, uh, service to others. And I think, um, you know, the, the platform, uh, experience and the user experience, the donor experience, all that I'd say innovating in, in more use cases like, uh, some of the ones you just heard that's what's next, and being able to, uh, use those guys more even externally to, uh, to do even more good for society, >>Leah, your thoughts with that. >>Well, um, you know, what I should really just getting started, right? So it's not a, you know, this transformation is now cloud enabled, uh, but, but w we're systematically actually going through our value chain, uh, and trying to throw the, understand, uh, you know, our customers, you know, again, as a business, we don't actually sell directly to consumers. So we're, we're, we're basically brokering through, but primarily through CPS and hospitals, right, to basically be able to diagnose a disease that can actually be cured with our products. Uh, and we do feel that, uh, you know, there is actually a huge role that we can actually play because obviously we're are experts in the, of, uh, you know, of the disease that we actually cure with our products. So basically the interactions, like the one that I just described nurse line, uh, can actually be directed, uh, not only to the HCPs, but also to the patients, uh, and the access to communities. >>Uh, and so we want to actually continue to provide platforms by which, you know, people that experienced, you know, especially a rare disease can now actually already connect and, uh, and, and, and share, um, you know, th th the sense of community that, that the business is, is so, so very important, right? For someone that physically has, uh, you know, the diseases that we cure. Uh, so again, uh, I think that the systematic approach of API APIs, and actually making sure that the data is actually ready for say the FDA to actually consume, to accelerate the clinical trials or to an hospital to kind of already understand if there is maybe a clinical trial that can be applied to one of the patients that is, that is actually showing some, some side effects that, uh, you know, or, or symptoms that visibly can be cured with, you know, with our, with our products, I think is going to be, uh, you know, ultimately the, the value that we can provide to society. So >>You guys did a great work and a great example. And to me, and this really showcases the management philosophy of cloud and the culture of cloud, where you take something like connect, and you can refactor and reconfigure these existing resources in a way that creates value, that saves lives. And this is the new, this new playbook. Congratulations on an exceptional story. I appreciate it. Thanks for coming on the cube coverage rapist, reinvent executive summit presented by Accenture I'm John ferry, your host, thanks for watching.